Tirzepatide is a glucagon-like peptide-1 (GLP-1) receptor agonist and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist, which means it is a biological peptide that can be sensitive to environmental conditions such as temperature and light
The data announced in December 2025 was impressive: Weight loss: Participants on the 12mg dose lost an average of 28.7% of their body weight (32.3 kg or 71.2 pounds) over 68 weeks
It changes how you read everything else in this article
Retatrutide is a triple receptor agonist targeting glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon (GCG) receptors
A Non-Prescription Option for Appetite Support The "GLP-1 Booster" name reflects the supplement's alignment with growing consumer interest in GLP-1-related pathways specifically those involved in appetite regulation, blood sugar modulation, and energy intake
GLP-1 medications help regulate appetite, blood sugar, and digestion
